Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression

Molecular Nutrition and Food Research

Volumn 60, Issue 11, 2016, Pages 2387-2395

  Zhang, Wei ^a,b   Chen, Jo Hsin ^c   Aguilera Barrantes, Irene ^c   Shiau, Chung Wai ^d   Sheng, Xiugui ^b   Wang, Li Shu ^c   Stoner, Gary D ^c   Huang, Yi Wen ^c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Black raspberry; Cell proliferation; Endometrial cancer; Estrogen receptor; Urolithin A

Indexed keywords

3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; COUMARIN DERIVATIVE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA;

CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DIET THERAPY; DRUG EFFECTS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETICS; HUMAN; METABOLISM; RUBUS;

CELL CYCLE; CELL PROLIFERATION; COUMARINS; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RUBUS;

EID: 84979519422     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600048     Document Type: Article

References (48)

1. Siegel, R. L., Miller, K. D., Jemal, A., Cancer statistics, Cancer J. Clin. 2016, 66, 7–30.
2. Khandekar, M. J., Cohen, P., Spiegelman, B. M., Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 2011, 11, 886–895.
3. von Gruenigen, V. E., Gil, K. M., Frasure, H. E., Jenison, E. L. et al., The impact of obesity and age on quality of life in gynecologic surgery. Am. J. Obstet. Gynecol. 2005, 193, 1369–1375.
4. Zhang, Q., Shen, Q., Celestino, J., Milam, M. R. et al., Enhanced estrogen-induced proliferation in obese rat endometrium. Am. J. Obstet. Gynecol. 2009, 200, 186.e1–8.
5. Joshi, A., Wang, H., Jiang, G., Douglas, W. et al., Endometrial tumorigenesis in Pten(+/−) mice is independent of coexistence of estrogen and estrogen receptor α. Am. J. Pathol. 2012, 180, 2536–2547.
6. Stoner, G. D., Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev. Res. 2009, 2, 187–194.
7. Wang, L. S., Burke, C. A., Hasson, H., Kuo, C. T. et al., A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev. Res. 2014, 7, 666–674.
8. Peiffer, D. S., Zimmerman, N. P., Wang, L. S., Ransom, B. W. et al., Chemoprevention of esophageal cancer with black raspberries, their component anthocyanins, and a major anthocyanin metabolite, protocatechuic acid. Cancer Prev. Res. 2014, 7, 574–584.
9. Mallery, S. R., Tong, M., Shumway, B. S., Curran, A. E. et al., Topical application of a mucoadhesive freeze-dried black raspberry gel induces clinical and histologic regression and reduces loss of heterozygosity events in premalignant oral intraepithelial lesions: results from a multicentered, placebo-controlled clinical trial. Clin. Cancer Res. 2014, 20, 1910–1924.
10. Shumway, B. S., Kresty, L. A., Larsen, P. E., Zwick, J. C. et al., Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin. Cancer Res. 2008, 14, 2421–2430.
11. Li, J., Zhang, D., Stoner, G. D., Huang, C., Differential effects of black raspberry and strawberry extracts on BaPDE-induced activation of transcription factors and their target genes. Mol. Carcinog. 2008, 47, 286–294.
12. Wang, L. S., Hecht, S. S., Carmella, S. G., Yu, N. et al., Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev. Res. 2009, 2, 84–93.
13. Cho, H., Jung, H., Lee, H., Yi, H. C. et al., Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells. Food Funct. 2015, 6, 1675–1683.
14. Kasimsetty, S. G., Bialonska, D., Reddy, M. K., Ma, G. et al., Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. 2010, 58, 2180–2187.
15. Gonzalez-Sarrias, A., Gimenez-Bastida, J., Nunez-Sanchez, M., Larrosa, M. et al., Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. Eur. J. Nutr. 2014, 53, 853–864.
16. Gonzalez-Sarrias, A., Gimenez-Bastida, J. A., Garcia-Conesa, M. T., Gomez-Sanchez, M. B. et al., Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol. Nutr. Food Res. 2010, 54, 311–322.
17. Seeram, N. P., Henning, S. M., Zhang, Y., Suchard, M. et al., Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J. Nutr. 2006, 136, 2481–2485.
18. Nunez-Sanchez, M. A., Garcia-Villalba, R., Monedero-Saiz, T., Gomez-Sanchez, M. B. et al., Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol. Nutr. Food Res. 2014, 58, 1199–1211.
19. Stoner, G. D., Wang, L. S., Seguin, C., Rocha, C. et al., Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats. Pharm. Res. 2010, 27, 1138–1145.
20. Wang, L. S., Hecht, S., Carmella, S., Seguin, C. et al., Berry ellagitannins may not be sufficient for prevention of tumors in the rodent esophagus. J. Agric. Food Chem. 2010, 58, 3992–3995.
21. Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A. et al., A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014, 4, 1387–1397.
22. Aarestrup, J., Kyro, C., Knudsen, K. E., Weiderpass, E. et al., Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women. Br. J. Nutr. 2013, 109, 2269–2275.
23. Horn-Ross, P. L., John, E. M., Canchola, A. J., Stewart, S. L. et al., Phytoestrogen intake and endometrial cancer risk. J. Natl. Cancer Inst. 2003, 95, 1158–1164.
24. Neill, A. S., Ibiebelem, T. I., Lahmann, P. H., Hughes, M. C. et al., Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case-control studies. Br. J. Nutr. 2014, 111, 1430–1440.
25. Bandera, E., Williams, M., Sima, C., Bayuga, S. et al., Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 2009, 20, 1117–1127.
26. Zeleniuch-Jacquotte, A., Lundin, E., Micheli, A., Koenig, K. L. et al., Circulating enterolactone and risk of endometrial cancer. Int. J. Cancer 2006, 119, 2376–2381.
27. Sabater-Molina, M., Larque, E., Torrella, F., Zamora, S., Dietary fructooligosaccharides and potential benefits on health. J. Physiol. Biochem. 2009, 65, 315–328.
28. Hsu, C. K., Liao, J. W., Chung, Y. C., Hsieh, C. P. et al., Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J. Nutr. 2004, 134, 1523–1528.
29. Bruno-Barcena, J. M., Azcarate-Peril, M. A., Galacto-oligosaccharides and colorectal cancer: feeding our intestinal probiome. J. Funct. Foods 2015, 12, 92–108.
30. Huang, Y. W., Liu, J. C., Deatherage, D. E., Luo, J. et al., Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 2009, 69, 9038–9046.
31. Larrosa, M., Gonzalez-Sarrias, A., Garcia-Conesa, M. T., Tomas-Barberan, F. A. et al., Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J. Agric. Food Chem. 2006, 54, 1611–1620.
32. Schroder, A. L., Pelch, K. E., Nagel, S. C., Estrogen modulates expression of putative housekeeping genes in the mouse uterus. Endocrine 2009, 35, 211–219.
33. Filby, A. L., Tyler, C.R., Appropriate ‘housekeeping’ genes for use in expression profiling the effects of environmental estrogens in fish. BMC Mol. Biol. 2007, 8, 1–13.
34. Larrosa, M., Gonzalez-Sarrias, A., Garcia-Conesa, M. T., Tomas-Barberan, F. A., Espin, J. C., Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J. Agric. Food Chem. 2006, 54,1611–1620.
35. Navari, J. R., Roland, P. Y, Keh, P., Salvesen, H. B. et al., Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5′ end of the ER gene. Clin. Cancer Res. 2000, 6, 4026–4032.
36. Castro-Rivera, E., Safe, S., Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. J. Steroid Biochem. Mol. Biol. 1998, 64, 287–295.
37. Deschenes, J., Bourdeau, V., White, J. H., Mader, S., Regulation of GREB1 transcription by estrogen receptor α through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J. Biol. Chem. 2007, 282, 17335–17339.
38. Nakamura, Y., Torikai, K., Ohto, Y., Murakami, A. et al., A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose- and timing-dependent enhancement and involvement of bioactivation by tyrosinase. Carcinogenesis 2000, 21, 1899–1907.
39. Tseng, T. H., Hsu, J. D., Lo, M. H., Chu, C. Y. et al., Inhibitory effect of Hibiscus protocatechuic acid on tumor promotion in mouse skin. Cancer Lett. 1998, 126, 199–207.
40. Swerdlow, A. J., Jones, M. E., British Tamoxifen Second Cancer Study Group., Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J. Natl. Cancer Inst. 2005, 97, 375–384.
41. Seeram, N. P., Aronson, W. J., Zhang, Y., Henning, S. M. et al., Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J. Agric. Food Chem. 2007, 55, 7732–7737.
42. Gimenez-Bastida, J. A., Gonzalez-Sarrias, A., Larrosa, M., Tomas-Barberan, F. et al., Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol. Nutr. Food Res. 2012, 56, 784–796.
43. Wada, L., Ou, B., Antioxidant activity and phenolic content of oregon caneberries. J. Agric. Food Chem. 2002, 50, 3495–3500.
44. Stoner, G. D., Sardo, C., Apseloff, G., Mullet, D. et al., Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J. Clin. Pharmacol. 2005, 45, 1153–1164.
45. Aiyer, H. S., Gupta, R. C., Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Cancer Prev. Res. 2010, 3, 727–737.
46. Mandal, S., Stoner, G. D., Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 1990, 11, 55–61.
47. Wang, N., Wang, Z. Y., Mo, S. L., Loo, T. Y. et al., Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res. Treat. 2012, 134, 943–955.
48. Zhao, M., Tang, S. N., Marsh, J. L., Shankar, S. et al., Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice. Cancer Lett. 2013, 337, 210–217.